BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
Fri, 19 Jan 2018 15:51:01 GMT

SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular disease...
Biopharmaceuticals, Cardiology, Personnel
MyoKardia, cardiomyopathy, mavacamten

UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer
Fri, 19 Jan 2018 15:48:13 GMT

40 years of industry experience in domestic and international markets related to Quality, Manufacturing, Supply Chain, Pharmaceutical Technology and Engineering BRISTOL, Tenn., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- UPM Pharmaceutic...
Biopharmaceuticals, Personnel
UPM Pharmaceuticals

Gathering Together World-Renowned Medical Device Manufacturing Suppliers, Medtec China Helps to Propel the Medical Device Localization Process
Fri, 19 Jan 2018 15:46:22 GMT

SHANGHAI, Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- To deliver a boost to the Medical Device Industry in China, the Chinese government has proactively launched several policies directed at medical device innovation which focus on speeding...
Devices, Regulatory
Medtec China

Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Fri, 19 Jan 2018 13:44:06 GMT

Results of tumor response assessments by blinded independent imaging review using both mRECIST and RECIST v1.1 criteria to be presented today at the Gastrointestinal Cancers Symposium WOODCLIFF LAKE, N.J., Jan. 19, 2018 -- (Healthcare Sales & Marketing ...
Biopharmaceuticals, Oncology
Eisai, REFLECT study, lenvatinib, Lenvima, hepatocellular carcinoma

Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Thu, 18 Jan 2018 15:43:29 GMT

BRIDGEWATER, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical Officer. La...
Diagnostics, Oncology, Personnel
Clinical Genomics, colorectal cancer, COLVERA, liquid biopsy

New Registry Launched to Track and Improve the Quality of Cancer Care Delivered in the U.S.
Thu, 18 Jan 2018 15:39:05 GMT

Quality Oncology Practice Initiative (QOPI®) Reporting Registry is a Joint Effort of Two Leading Oncology Societies ALEXANDRIA, Va., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- A registry that tracks the quality of medical care provid...
Devices, Oncology, Product Launch
ASTRO, ASCO, Quality Oncology Practice Initiative, radiotherapy

Smith and Nephew's Episode of Care Assurance Program (eCAP) reduces hospital readmission following total joint replacement surgery
Thu, 18 Jan 2018 13:14:26 GMT

LONDON, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces results showing a near 75% decrease in readmission rates for joint arthroplasties (TJA) conduct...
Devices, Orthopaedic
Smith & Nephew, Episode of Care Assurance Program, total joint arthroplasty

Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome
Thu, 18 Jan 2018 13:05:05 GMT

WARREN, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application for clobazam Oral Soluble Fil...
Biopharmaceuticals, Neurology, Drug Delivery, FDA
Aquestive Therapeutics, clobazam, Oral Soluble Film, Lennox-Gastaut syndrome

Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial
Thu, 18 Jan 2018 12:58:46 GMT

SAN ANTONIO, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its f...
Devices, Interventional
Bluegrass Vascular Technologies, Surfacer, Surfacer Inside-Out, Access Catheter

Lannett Names Timothy C. Crew To Board Of Directors
Thu, 18 Jan 2018 12:53:25 GMT

PHILADELPHIA, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed chief executive officer (CEO), has been added to the Lannett Company Board of...
Biopharmaceuticals, Generics, Personnel

Source: HSMN NewsFeed